BRUFEN

This brand name is authorized in Albania, Australia, Austria, Croatia, Cyprus, Estonia, France, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Tunisia, Turkey, UK.

Active ingredients

The drug BRUFEN contains one active pharmaceutical ingredient (API):

1	Ibuprofen UNII WK2XYI10QM - IBUPROFEN
	Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.
	Read more about Ibuprofen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BRUFEN 400 mg Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE01	Ibuprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	222/181
AU	Pharmaceutical Benefits Scheme	3190X, 3192B, 5123P, 5124Q, 5368M
EE	Ravimiamet	1424124, 1424135, 1424258, 1424269, 1424348, 1424359, 1513437, 1513448, 1513459, 1513460, 1538221, 1538232, 1557389, 1557390, 1557402, 1557413, 1557424, 1601895, 1602098, 1602100, 1602111, 1602122
FR	Base de données publique des médicaments	65573720
GB	Medicines & Healthcare Products Regulatory Agency	175342, 185475, 198667, 22517, 225753, 27861, 299805, 299807, 32394, 373801, 373803, 381229
HK	Department of Health Drug Office	54288, 54601, 65974
HR	Agencija za lijekove i medicinske proizvode	HR-H-053171042, HR-H-071108593, HR-H-254292502, HR-H-290369954, HR-H-330150785, HR-H-334193871, HR-H-355286054, HR-H-496875141, HR-H-532068337, HR-H-548019973, HR-H-765431689, HR-H-794772028, HR-H-922117795
IE	Health Products Regulatory Authority	15644, 16973, 16986, 67573
IT	Agenzia del Farmaco	022593103, 022593204, 022593216, 039693039, 041238015, 041240019, 041240033, 041746013, 042830012, 042859013, 042859025, 042859037, 042996013, 043101017, 043890019, 044661015
JP	医薬品医療機器総合機構	1149001D1160, 1149001F1455, 1149001F2168
LT	Valstybinė vaistų kontrolės tarnyba	1038436, 1038437, 1038438, 1053398, 1053399, 1053400, 1058290, 1058291, 1061472, 1061473, 1061814, 1065142, 1069547, 1069548, 1071131, 1071132, 1071133, 1071134
MT	Medicines Authority	MA1507/02901, MA1507/02902, MA1507/03001, PI1438/04501A, PI1438/04502A, PI770/15501A
NL	Z-Index G-Standaard	13563149
NL	Z-Index G-Standaard, PRK	31321, 33154
NZ	Medicines and Medical Devices Safety Authority	10790, 11539, 13702, 19450, 19892, 990
PL	Rejestru Produktów Leczniczych	100249417
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68648001, W68648002, W68648003, W68648004, W68648005, W68648006, W68648007, W68649001, W68649002, W68649003, W68649004, W68649005, W68649006, W68650001, W68650002
SG	Health Sciences Authority	05443P, 05722P
TN	Direction de la Pharmacie et du Médicament	5873111
TR	İlaç ve Tıbbi Cihaz Kurumu	8699548033162, 8699548093159, 8699548094408, 8699548123221
ZA	Health Products Regulatory Authority	27/2.7/0226, 27/3.1/0396, A/3.1/727, H/3.1/39, Q/3.1/323, R/3.1/71, Y/3.1/13, Z/3.1/173